Purchase Order HHSN268201700058A

Award Date 1/1/17
Potential Completion Date 12/31/17
Potential Value $139K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a firm fixed-price purchase order contract worth $192,612.75 to Biofortis, LLC, a for-profit limited liability company. The contract is for custom development and ad hoc services related to the Labmatrix software platform, which is used to track research information, biospecimens, and results to support data management needs for cancer and genomics research programs at...
This is a federal contract award by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Biofortis, LLC. The contract is for a LABMATRIX software subscription, with a ceiling value of $95,274.00. The contract is a firm fixed price purchase order, with a period of performance through December 31, 2016. Biofortis is a clinical trial laboratory services organization that provides software solutions, including the LABMATRIX platform, to support...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm-fixed-price purchase order to Biofortis, LLC, a for-profit limited liability company, for a Labmatrix software subscription renewal. The contract has a total potential value of $184,675.25 and a period of performance through December 31, 2020. Labmatrix is a specialized software platform that tracks research information, biospecimens, and results to support data...
This is a firm fixed price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to Biofortis, LLC, a for-profit limited liability company. The contract is for a Labmatrix software license, with a ceiling value of $78,746.80 and a period of performance through June 27, 2023. Biofortis, which specializes in clinical trial laboratory services and software solutions, has...
This federal contract award to Biofortis, LLC by the National Heart Lung and Blood Institute, part of the National Institutes of Health, is a $96,697 firm fixed price purchase order for Labmatrix software subscriptions, maintenance, development support services, and training. Biofortis provides a specialized software platform that tracks research information, biospecimens, and results to support data management needs for the Institute's cancer and genomics research programs. This contract...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) to Biofortis, LLC, a for-profit limited liability company. The contract is for a one-year software license renewal for the Labmatrix system, which supports data management for cancer and genomics research programs at the NIH's National Cancer Institute and National Human Genome Research Institute. The potential value of the award is $154,750.00. No...
This is a firm fixed price purchase order award to Biofortis, LLC, a for-profit limited liability company, by the Office of Logistics and Acquisition Operations at the U.S. Department of Health and Human Services. The $79,109.38 contract provides a software subscription, maintenance, development support services, and training for the Labmatrix platform, which supports data management for cancer and genomics research programs at the National Cancer Institute and National Human Genome Research...
This is a firm-fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Biofortis, LLC, a clinical trial laboratory services organization. The contract is for a Labmatrix Named User License, which provides software subscriptions, maintenance, development support services, and training for Labmatrix - a specialized software platform that tracks research information, biospecimens, and results to support data management needs for cancer and genomics research...
<p>This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Genologics Life Sciences Software Inc. for a software license for the Clarity LIMS Gold Edition. The contract has a ceiling value of $119,677.00 and a period of performance ending on September 27, 2016. There is no set-aside designation for this contract. The contract was awarded on September 29, 2015.</p>
This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Uberresearch Inc. for portfolio analysis, reviewer finder, and dimensions support. The contract has a ceiling value of $577,200.00 and an ultimate completion date of February 7, 2017. The contract has no set-aside designation. Based on the agency and contract description, this work likely supports NHLBI's...

This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract has a ceiling value of $139,009.50 and an ultimate completion date of December 31, 2017. The prime contractor is Biofortis, LLC, a for-profit limited liability company that provides software solutions and services to support clinical trials and translational research programs. The contract enables the NHLBI to acquire Labmatrix software subscriptions, maintenance, development support services, and training to track research information, biospecimens, and results for its cancer and genomics research programs. This contract award was not set aside for any special designation.

Generated 4/2/25, 10:54 PM